NXTC NextCure Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik nextcure.com (NXTC)

Risks for NextCure, Inc. (NXTC) are linked to fierce competition in early-stage immuno-oncology. On GURU.Markets, current EV/Sales price action has identified a support level where the value stabilized at 0.00. Stability is underpinned by low antibody production costs during scaling and the diversification of treatment approaches for various types of cancer to combat therapy resistance.

Nilai perusahaan marang pendapatan: NextCure Inc (NXTC) kanggo 23.11.2025 - 20.11.2026

nextcure.com - rincian analitis lan metrik utama (NXTC)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:NextCure, Inc. NXTC
Sampel barang NextCure, Inc.

Professional managers utilize fundamental filters to separate overvalued assets from undervalued ones by analyzing business value relative to net debt to sales. In the case of NextCure, Inc. (NXTC), the EV/Sales multiple trend reflects market expectations for the scaling of its immuno-oncology portfolio, allowing for an assessment of whether the current capitalization is justified by the potential of new antibodies to combat tumor resistance.

Analisis pesaing NextCure, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP